%PDF-1.7
%
4 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
7 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
3 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
13 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
11 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
12 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
5 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
10 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
9 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
6 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
1 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
8 0 obj
<>>>/BBox[0 0 585 783]/Length 135>>stream
x5;!SL<~QK^@.f<l
If.fb
; } ?avt#=rbkv)c~Q{ּz xT\n_'R\o̺
*z
endstream
endobj
15 0 obj
<>stream
application/pdfZIF-8 with encapsulated dihydroartemisinin in a drug delivery system for protection against Plasmodium berghei ANKA-induced experimental cerebral malaria in C57BL/6N miceSpectrum02366-24Yuting LiLiu-Gen LiHuiyin ZhuDaiqian ZhuHaimei ShiWei WangJinyu MoJianhai YinTong-fei LiJian LiYuting LiLiu-Gen LiHuiyin ZhuDaiqian ZhuHaimei ShiWei WangJinyu MoJianhai YinTong-fei LiJian LiAmerican Society for MicrobiologyCopyright © 2025 Li et al.This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.20252023Cerebral malaria (CM), primarily caused by Plasmodium falciparum, is the primary cause of malaria-related fatalities. CM treatment faces significant challenges due to limited therapeutic options and the emergence of antimalarial drug resistance. Dihydroartemisinin (DHA) is the first-line therapeutic agent for malaria. However, it encounters limitations such as poor solubility, inadequate selectivity, and rapid elimination. Here, we introduced a facile and effective approach using zeolite imidazolium framework-8 (ZIF-8) encapsulated with DHA (DHA@ZIF-8) and assessed its therapeutic efficacy in an experimental cerebral malaria model. The DHA@ZIF-8 demonstrated excellent drug-loading capacity, high stability, prolonged drug release, and improved targeted elimination of Plasmodium parasites within infected red blood cells (iRBCs). This minimized damage to brain microvascular endothelial cells (BMECs) and protected organs from injury, increasing the survival time of the infected mice. Compared to free DHA, DHA@ZIF-8 exhibited better antimalarial efficacy and almost no side effects. This study highlights ZIF-8’s potential as a reliable, stable, and efficient drug delivery vector for DHA to improve CM therapy.For the treatment of human malaria, artemisinin-based drugs remain the first-line treatment option. However, their utility is constrained by their short half-life in vivo. Consequently, extending the duration for drug efficacy in the body is a critical issue that needs to be addressed. Metal-organic frameworks are a promising choice for drug loading. In the present study, DHA@ZIF-8 and DHA@MOF were constructed and characterized and were assessed in an experimental cerebral malaria model of C57BL/6 N mice induced by Plasmodium berghei ANKA strain. Data show that DHA@ZIF-8 has a worthy therapeutic effect on experimental cerebral malaria. It will offer a new option for human cerebral malaria (HCM) treatment.20240921202505212165-0497uuid:8b635f07-4416-4a8b-bae7-27e1ffc70b58uuid:66b0a38a-a553-48c2-af17-5752dba1fb57
Antenna House PDF Output Library 7.4.1901; modified using iText 4.2.0 by 1T3XT
Antenna House XSL Formatter V7.4 MR2 Linux : 7.4.3.63807 (2024-03-22T11:49+09)
2025-06-19T11:44:52+00:00
2025-09-25T08:25:29-07:00
2025-09-25T08:25:29-07:00
8f3b4ad1-6126-442d-8986-8298ace40b7f
1
endstream
endobj
16 0 obj
<>stream
x+ |
endstream
endobj
17 0 obj
<>stream
xS**T0T0 Bi yA$
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
xS**T0T0 Bi yn)
endstream
endobj
20 0 obj
<>stream
x+ |
endstream
endobj
21 0 obj
<>stream
xS**T0T0 Bi y+
endstream
endobj
22 0 obj
<>stream
x+ |
endstream
endobj
23 0 obj
<>stream
xS**T0T0 Bi y\'
endstream
endobj
24 0 obj
<>stream
x+ |
endstream
endobj
25 0 obj
<>stream
xS**T0T0 Bih lT
endstream
endobj
26 0 obj
<>stream
x+ |
endstream
endobj
27 0 obj
<>stream
xS**T0T0 Bi yw*
endstream
endobj
28 0 obj
<>stream
x+ |
endstream
endobj
29 0 obj
<>stream
xS**T0T0 Bih uU
endstream
endobj
30 0 obj
<>stream
x+ |
endstream
endobj
31 0 obj
<>stream
xS**T0T0 Bi y8#
endstream
endobj
32 0 obj
<>stream
x+ |
endstream
endobj
33 0 obj
<>stream
xS**T0T0 Bi y,
endstream
endobj
34 0 obj
<>stream
x+ |
endstream
endobj
35 0 obj
<>stream
xS**T0T0 Bi yS&
endstream
endobj
36 0 obj
<>stream
x+ |
endstream
endobj
37 0 obj
<>stream
xS**T0T0 Bi yJ%
endstream
endobj
38 0 obj
<>stream
x+ |
endstream
endobj
39 0 obj
<>stream
xS**T0T0 Bi ye(
endstream
endobj
52 0 obj
<>stream
xڭ\[sܸ~_Gꔆ&`U*lgY{&>Cřu:?t RME>n_% pٓ/3J#G a2ֆ2>{Uܝs?go_/0t8UFoxkJ^gB࿗oW@CVSIMS2yz~JHJn>kqYɿ"a*/8^e} ]%7?7+ܳwX;)\_&GI46;ruAxŦ̝xbЯN.%XI
lX%!_&;42̷d[`6*zh{J:s⑻h_4EUTtGyYfo,zhBI"qIfeQ"> ,@A]VTqP~6q"$]f;[-N{rvn./@
CF$
$ŕ
KZkTxVj{ ")&!/y3;f%q_Z[>gev_d7R?zKw1O
:RcT*{E"ӱ&E1`á1 7h-P1
&V"MSNNϑ1qb4L'8\8QGxPMJMcŴalWb.%Wʧgid`X13}b?E55%hܝ..7IAJ?}3E5M9]
aȊ/E6 IQb#M8bXY2+:V!7f
4Fx)x遲f鋩AgQD0T4K(rTgq
TMХR(:~٨>@chh0x6t1FqbSXr!<OĊ'rd@&3VƉѣ2Ɠl\k11;DKRxޏ]6qP`p-8w:ʸNbl
qS319yH͗znq>Ԯ8:KJfOD6c^Nl@TNJ*
J+fLM$4KVjJ;5] )!ʩg@gTo@RuMi!1/
tn
}ޓW^>14yq&WR3#~B?"ɦGǜ%1AX8v}dIRé*